Ultragenyx to Present at the Baird 2017 Global Healthcare Conference
NOVATO, Calif., Aug. 31, 2017 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company focused on the development of novel products for rare and ultra-rare diseases, today announced that Emil Kakkis, M.D., Ph.D., the …